The latest call
FetchingHyperfine, Inc. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$0.63-6.6%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 9, 2026
Company outlook: revenue of $20M to $22M for Fiscal year 2026 — up 54.8% on a year earlier, slower than the 73.4% just reported
Just reported
From Hyperfine, Inc.'s results release of November 9, 2026; its quarterly report has since been filed.
Actual
$6M
+73% y/y
+53% q/q
Guided
—
No guide given
Actual
-$0.06
Guided
—
No guide given
Actual
-$7.3M
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $6M | $3.4M | +73.41% |
| Profit | -$6M | -$11M | +45.72% |
| Profit per share | -$0.06 | -$0.14 | +57.14% |
| Free Cash Flow | -$6.1M | -$5.7M | -6.86% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Hyperfine, Inc. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Q3 2026 marked the beginning of a new trajectory for Hyperfine. We delivered record revenue, gross profit, and gross margin, and for the first time quarterly revenue exceeded net cash burn, demonstrating the operating leverage of our business. The combination of AI with accessible brain imaging enables diagnostic insights at scale, sooner, and in more care settings, from the health system to the community. Beyond our current business, I am excited about the opportunities for our Swoop ® system in the evolving brain health and longevity fields. This is the new Hyperfine,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Hyperfine, Inc.’s Item 2.02 8-K filed November 9, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.